← FDA DRUG APPROVALS

FDA ANDA · ANDA071367

VERAPAMIL HYDROCHLORIDE

Sponsor: WATSON LABS

APPLICATION
ANDA071367
TYPE
ANDA
ORIGINAL APPROVAL
1986-10-01
LATEST ACTION
2007-04-12
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

VERAPAMIL HYDROCHLORIDEDiscontinued
VERAPAMIL HYDROCHLORIDE 120MG · TABLET · ORAL

Approval history

2007-04-12Manufacturing (CMC) · Supplement 25AP
2002-11-07Manufacturing (CMC) · Supplement 23AP
2002-06-25Manufacturing (CMC) · Supplement 22AP
2002-05-21Manufacturing (CMC) · Supplement 20AP
2001-08-31Manufacturing (CMC) · Supplement 19AP
1999-11-10Manufacturing (CMC) · Supplement 18AP
1998-08-26Labeling · Supplement 17AP
1996-04-10Labeling · Supplement 16AP
1993-06-30Labeling · Supplement 14AP
1992-12-02Labeling · Supplement 15AP
1991-02-05Labeling · Supplement 13AP
1989-11-13Labeling · Supplement 5AP
1987-03-03Manufacturing (CMC) · Supplement 3AP
1987-03-03Manufacturing (CMC) · Supplement 1AP
1987-03-03Manufacturing (CMC) · Supplement 4AP
1987-03-03Manufacturing (CMC) · Supplement 2AP
1986-10-01OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →